Implantable Neurostimulators Market Incredible Possibilities, Growth with Industry Study, Top Key Players (NeuroPace, NeuroSigma, Medtronic, Boston Scientific, St Jude Medical, Cyberonics, Synapse Biomedical) and Forecast to 2023

A market study ”Global Implantable Neurostimulators Market” examines the performance of the Global Implantable Neurostimulators Market 2019. It encloses an in-depth Research of the Implantable Neurostimulators Market state and the competitive landscape globally. This report analyzes the potential of Implantable Neurostimulators Market in the present and the future prospects from various angles in detail.

Global Implantable Neurostimulators Market Overview:

The Global Implantable Neurostimulators Market research report is the investigation arranged by investigators, which contain a point by point examination of drivers, limitations, and openings alongside their effect on the Implantable Neurostimulators Market development (2019 - 2023).

Some of the significant key factors driving the growth of the Global Implantable Neurostimulators Market are rapid growth in adoption of neurostimulation devices by physicians and the rising prevalence of chronic neuro-muscular disorders. However, the discomfort caused by the invasive surgical procedure for implanting the device which is also expensive is a major restraint for the market. The trend of outsourcing medical devices is being adopted by manufacturers, propelling the market globally.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/102611 .

The Global Implantable Neurostimulators Market is segmented in the basis of Type, Application and Region. Based on the Type, the Global Implantable Neurostimulators Market is classified into Deep Brain Stimulators, Spinal Cord Stimulators, Vagal Nerve Stimulators, Sacral Nerve Stimulators, and others. On the b basis of Application, the Global Implantable Neurostimulators Market is sub-segmented into Parkinson’s disease, Epilepsy, Pain, and Others.

Industry Updates:

1 NeuroSigma (April 23, 2019) – NeuroSigma Announces FDA Clearance of Monarch eTNS System as First Non-Drug Treatment for Pediatric ADHD – NeuroSigma, Inc., a Los Angeles-based bioelectronics company focused on commercializing Trigeminal Nerve Stimulation (TNS) technology for treating neurological and neuropsychiatric disorders today announced that its Monarch eTNS System (Monarch) received FDA clearance as a non-drug treatment for attention deficit hyperactivity disorder (ADHD).

The prescription-only Monarch device is indicated for treatment of pediatric ADHD as a monotherapy in patients ages 7 through 12 years old who are not currently taking prescription ADHD medications.  The device is intended to be used in the home under the supervision of a caregiver during periods of sleep.

"We are extremely pleased by FDA's clearance of the Monarch as a monotherapy for pediatric ADHD.  We want to thank the FDA team for their efforts during the review process to bring it to a timely and successful completion," said Leon Ekchian, Ph.D., President & CEO of NeuroSigma.  "We also want to applaud the efforts of the clinical team at UCLA.  We look forward to building a commercial organization in the U.S. to offer children, their parents and their physicians a compelling, low-risk, non-drug alternative to current medication treatment options for ADHD," added Ekchian.

2 NeuroPace (February 12, 2019) – NeuroPace Announces New Category I CPT Code from AMA for Electrocorticography from an Implanted Brain Neurostimulator – NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced that the American Medical Association (AMA) has issued a new Category I Current Procedural Terminology (CPT®) code for electrocorticography from an implanted brain neurostimulator. The new code is applicable to services that physicians perform with the company’s RNS® System, a first-of-its-kind technology for the treatment of patients with refractory epilepsy.

Beginning January 1, 2019, providers are able to report the new CPT code for the review and interpretation of electrocorticograms (measurements of brain activity) captured and stored by the RNS System. CPT codes are widely recognized by public and private health insurance payers in the United States to describe healthcare services and procedures to facilitate reimbursement. The CPT code application was submitted by the American Academy of Neurology, American Clinical Neurophysiology Society, and the National Association of Epilepsy Centers.

Top Leading Key Manufacturers are: Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, NeuroPace, Synapse Biomedical, NeuroSigma, EnteroMedics, ElectroCore Medical, Inspire Medical, NEUROS, SPR, IMTHERA, NEVRO and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

With the presence of a large pool of participants, the Global Implantable Neurostimulators Market is displaying a highly competitive business landscape, finds a new research report by Business Industry Reports (BIR). Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, NeuroPace, Synapse Biomedical, NeuroSigma, EnteroMedics, ElectroCore Medical, Inspire Medical, NEUROS, SPR, etc. are some of the key vendors of Implantable Neurostimulators across the world. These players across Implantable Neurostimulators Market are focusing aggressively on innovation, as well as on including advanced technologies in their existing products.

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Implantable Neurostimulators Market Report 2019” @ https://www.businessindustryreports.com/buy-now/102611/single .

Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Implantable Neurostimulators in these regions, from 2013 to 2023 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.